Compare Rocket Lab USA Inc (RKLB) vs UnitedHealth Group Inc (UNH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Rocket Lab USA Inc vs UnitedHealth Group Inc — how do they compare? Rocket Lab USA Inc trades at $69.5 (market cap $43.19B), while UnitedHealth Group Inc trades at $431.76 (market cap $396.27B). The key difference: UnitedHealth Group Inc is far larger — about 9.2× Rocket Lab USA Inc's market cap, and UnitedHealth Group Inc pays a 2.13% dividend while Rocket Lab USA Inc pays none. Which is the better fit depends on your goals.
| RKLB | UNH | |
|---|---|---|
Market Cap | $43.19B | $396.27B |
Sector | Technology | Health |
52-Week High | $150.23 | $436.35 |
52-Week Low | $39.48 | $237.77 |
Enterprise Value | $41.94B | $442.96B |
Dividend Yield | — | 2.13% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Rocket Lab (RKLB) trades at $65.74, down 2.78% on the day, with a bearish technical signal despite oscillators suggesting oversold conditions. The company reported a net loss of $198.21 million in 2025, though revenue grew to $601.80 million. Recent positive news includes a $266 million defense contract awarded on July 21, 2026, per Benzinga, providing a near-term catalyst amid broader sector volatility.
The outlook remains high-risk with negative profitability but strong analyst support; 75% recommend Buy with a $116.90 consensus target. Key risks include execution delays on the Neutron rocket and intense competition. Upside depends on contract execution and path to profitability, while downside stems from cash burn and market sentiment shifts.
UnitedHealth Group (UNH) trades at $421.55, down 1.07% on the day, with a bullish technical outlook supported by moving averages and ADX signals. The company reported strong Q2 2026 EPS of $6.38, beating estimates, and maintains robust cash flow generation. Recent news highlights strategic moves to reduce pediatric prior authorizations and ongoing shareholder returns through dividends and buybacks.
UNH presents a favorable investment case with 82.7% analyst buy ratings and a $476.50 consensus price target, implying 13% upside. Risks include regulatory scrutiny from lawsuits and Medicaid fraud allegations, while demographic trends and operational efficiency support long-term growth. The stock's valuation at a P/E of 31.74 reflects premium pricing relative to historical margins.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Rocket Lab USA Inc
Rocket Lab USA, Inc. is an aerospace manufacturer and small-satellite launch service provider. The company specializes in developing rockets for orbital launch, including its flagship *Electron* vehicle, and is developing the next-generation, reusable *Neutron* rocket. Beyond launch services, Rocket Lab also offers satellite design, manufacturing, and spacecraft component solutions, positioning itself as an end-to-end provider for the space industry.
Read more on RKLB →About UnitedHealth Group Inc
UnitedHealth Group is one of the largest private health insurers, providing medical benefits to 50 million members globally, including 5 million outside the U.S. at the end of 2021. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in managed care. Along with its insurance assets, UnitedHealth's continued investments in its Optum franchises have created a healthcare services colossus that spans everything from medical and pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.
Read more on UNH →
